Precision medicine improves outcomes in metastatic breast cancer

被引：0
|
作者：
Gennari, Alessandra [1 ]
机构：
[1] Univ Piemonte Orientale, Novara, Italy
来源：
NATURE | 2022年
关键词：
Genomics; Cancer; Personalized medicine;
D O I：
10.1038/d41586-022-02276-9
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
For breast cancers that have spread, a randomized phase II clinical trial shows that using genomic analysis to target therapies can improve outcomes, but only in people with a genetic alteration that has previously been associated with antitumour activity in clinical trials.
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Precision medicine for metastatic breast cancer—limitations and solutions
    Monica Arnedos
    Cecile Vicier
    Sherene Loi
    Celine Lefebvre
    Stefan Michiels
    Herve Bonnefoi
    Fabrice Andre
    Nature Reviews Clinical Oncology, 2015, 12 : 693 - 704
  • [2] From precision medicine to personalized medicine in metastatic breast cancer patients
    Andre, Fabrice
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [3] Precision medicine for metastatic breast cancer-limitations and solutions
    Arnedos, Monica
    Vicier, Cecile
    Loi, Sherene
    Lefebvre, Celine
    Michiels, Stefan
    Bonnefoi, Herve
    Andre, Fabrice
    NATURE REVIEWS CLINICAL ONCOLOGY, 2015, 12 (12) : 693 - 704
  • [4] Precision genomic medicine improves clinical outcomes in advanced cancer patients
    Nadauld, Lincoln D.
    Van Norman, Burke
    Fulde, Gail
    Newman, David
    Butler, Allison
    Tudor, Brian
    Gilbert, Heather
    Lin, Karen
    Stone, Gary
    Konde, Anish
    Petrovchich, Iva
    Ford, James M.
    Haslem, Derrick
    CLINICAL CANCER RESEARCH, 2016, 22
  • [5] Precision medicine for HER2 negative metastatic breast cancer
    Hara, Fumikata
    ANNALS OF ONCOLOGY, 2016, 27
  • [6] Precision medicine in breast cancer
    Naito, Yoichi
    Urasaki, Tetsuya
    CHINESE CLINICAL ONCOLOGY, 2018, 7 (03)
  • [7] Accelerating precision medicine in metastatic prostate cancer
    Joaquin Mateo
    Rana McKay
    Wassim Abida
    Rahul Aggarwal
    Joshi Alumkal
    Ajjai Alva
    Felix Feng
    Xin Gao
    Julie Graff
    Maha Hussain
    Fatima Karzai
    Bruce Montgomery
    William Oh
    Vaibhav Patel
    Dana Rathkopf
    Matthew Rettig
    Nikolaus Schultz
    Matthew Smith
    David Solit
    Cora Sternberg
    Eliezer Van Allen
    David VanderWeele
    Jake Vinson
    Howard R. Soule
    Arul Chinnaiyan
    Eric Small
    Jonathan W. Simons
    William Dahut
    Andrea K. Miyahira
    Himisha Beltran
    Nature Cancer, 2020, 1 : 1041 - 1053
  • [8] Accelerating precision medicine in metastatic prostate cancer
    Mateo, Joaquin
    McKay, Rana
    Abida, Wassim
    Aggarwal, Rahul
    Alumkal, Joshi
    Alva, Ajjai
    Feng, Felix
    Gao, Xin
    Graff, Julie
    Hussain, Maha
    Karzai, Fatima
    Montgomery, Bruce
    Oh, William
    Patel, Vaibhav
    Rathkopf, Dana
    Rettig, Matthew
    Schultz, Nikolaus
    Smith, Matthew
    Solit, David
    Sternberg, Cora
    Van Allen, Eliezer
    VanderWeele, David
    Vinson, Jake
    Soule, Howard R.
    Chinnaiyan, Arul
    Small, Eric
    Simons, Jonathan W.
    Dahut, William
    Miyahira, Andrea K.
    Beltran, Himisha
    NATURE CANCER, 2020, 1 (11) : 1041 - 1053
  • [9] Precision medicine in breast cancer (Review)
    Papalexis, Petros
    Georgakopoulou, Vasiliki Epameinondas
    Drossos, Panagiotis V.
    Thymara, Eirini
    Nonni, Aphrodite
    Lazaris, Andreas C.
    Zografos, George C.
    Spandidos, Demetrios A.
    Kavantzas, Nikolaos
    Thomopoulou, Georgia Eleni
    MOLECULAR AND CLINICAL ONCOLOGY, 2024, 21 (05)
  • [10] Breast cancer in the era of precision medicine
    Sarhangi, Negar
    Hajjari, Shahrzad
    Heydari, Seyede Fatemeh
    Ganjizadeh, Maryam
    Rouhollah, Fatemeh
    Hasanzad, Mandana
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (10) : 10023 - 10037
12345